![ACHBT on Twitter: "Pour ceux qui ont raté notre Premier Grand Round de l'ACHBT sur la thématique "Adénocarcinome pancréatique Borderline" animé par Fabien Robin (Rennes) / Expert : Jean-Robert Delpero c'est en ACHBT on Twitter: "Pour ceux qui ont raté notre Premier Grand Round de l'ACHBT sur la thématique "Adénocarcinome pancréatique Borderline" animé par Fabien Robin (Rennes) / Expert : Jean-Robert Delpero c'est en](https://pbs.twimg.com/media/E1Wsj6xWEAoqZx1.jpg)
ACHBT on Twitter: "Pour ceux qui ont raté notre Premier Grand Round de l'ACHBT sur la thématique "Adénocarcinome pancréatique Borderline" animé par Fabien Robin (Rennes) / Expert : Jean-Robert Delpero c'est en
![A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design – topic A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design – topic](https://cyberleninka.org/viewer_images/775141/f/1.png)
A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design – topic
![Jean Robert DELPERO | EMERITUS PROFESSOR | Professor | Institut Paoli Calmettes, Marseille | Surgery | Research profile Jean Robert DELPERO | EMERITUS PROFESSOR | Professor | Institut Paoli Calmettes, Marseille | Surgery | Research profile](https://www.researchgate.net/publication/343455287/figure/fig1/AS:932488419504128@1599333972144/Survival-in-patients-who-benefit-1a-or-not-1b-from-resection-according-to-period-of_Q320.jpg)
Jean Robert DELPERO | EMERITUS PROFESSOR | Professor | Institut Paoli Calmettes, Marseille | Surgery | Research profile
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor
Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreat
Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradi
NEOADJUVANT PREOPERATIVE CHEMORADIATION IN PATIENTS WITH PANCREATIC CANCER VALERIE MAGNIN, M.D.,* VINCENT MOUTARDIER, M.D.,† M
![Kjetil Søreide on Twitter: "Excited to attend PhD defence for Dyre Kleive soon @UniOslo @Oslounivsykehus #pancreaticsurgery with oponents from 🇮🇹 and 🏴 @ProfW_edinsurg @EdinSurg @hpb_so https://t.co/h1EancoDph" / Twitter Kjetil Søreide on Twitter: "Excited to attend PhD defence for Dyre Kleive soon @UniOslo @Oslounivsykehus #pancreaticsurgery with oponents from 🇮🇹 and 🏴 @ProfW_edinsurg @EdinSurg @hpb_so https://t.co/h1EancoDph" / Twitter](https://pbs.twimg.com/media/D9kcnQ4XsAAS4vv.jpg:large)